Prognostic significance of vascular and lymphatic emboli in resected pulmonary adenocarcinoma

Annals of Thoracic Surgery

Volumn 95, Issue 4, 2013, Pages 1204-1210

  Strano, Salvatore ^a   Lupo, Audrey ^a   Lococo, Filippo ^a,b   Schussler, Olivier ^a   Loi, Mauro ^a   Younes, Mohamad ^a   Bobbio, Antonio ^a   Damotte, Diane ^a   Regnard, Jean François ^a   Alifano, Marco ^a  

^a HÔTEL DIEU   (France)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE ASSOCIATION; EMBOLISM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG RESECTION; LYMPHATIC EMBOLUS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL PREDICTION; VASCULAR EMBOLUS;

ADENOCARCINOMA; AGED; BLOOD VESSELS; EMBOLISM; FEMALE; FRANCE; HUMANS; LUNG NEOPLASMS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PNEUMONECTOMY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84875289379     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.12.024     Document Type: Article

References (23)

1. A.J. Alberg, J.G. Ford, J.M. Samet Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines Chest 132 Suppl 3 2007 29 55
2. D.R. Youlden, S.M. Cramb, P.D. Baade The international epidemiology of lung cancer: geographical distribution and secular trends J Thorac Oncol 3 2008 819 831
3. M.J. Higgins, D.S. Ettinger Chemotherapy for lung cancer: the state of the art in 2009 Expert Rev Anticancer Ther 9 2009 1365 1378
4. A.B. Custodio, J.L. González-Larriba, J. Bobokova Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer J Thorac Oncol 4 2009 891 910
5. G.R. Simon Individualizing chemotherapy for non-small cell lung cancer (NSCLC) in the adjuvant and advanced setting: current status and future directions Curr Treat Options Oncol 9 2008 300 312
6. H.A. Wakelee, J.H. Schiller, D.R. Gandara Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the new Intergroup trial Clin Lung Cancer 8 2006 18 21
7. V. Rigau, T.J. Molina, C. Chaffaud Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence Lung Cancer 38 2002 169 176
8. T.C. Mineo, V. Ambrogi, A. Baldi Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumor vessel invasion after radical surgery for IB-IIA non-small cell lung cancer J Clin Pathol 57 2004 591 597
9. O.A. Khan, J.J. Fitzgerald, M.L. Field Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung Ann Thorac Surg 77 2004 1173 1178
10. R. Kessler, B. Gasser, G. Massard Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer Ann Thorac Surg 62 1996 1489 1493
11. T. Tsuchiya, S. Akamine, M. Muraoka Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy Lung Cancer 56 2007 341 348
12. T. Tsuchiya, S. Hashizume, S. Akamine Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer Chest 132 2007 170 177
13. S. Gabor, H. Renner, H. Popper Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer Eur J Cardiothorac Surg 25 2004 439 442
14. A.J. Poncelet, J. Cornet, C. Coulon, P. Collard, P. Noirhomme, B. Weynand Groupe d'Oncologie Thoracique des Cliniques Saint-Luc Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma Eur J Cardiothorac Surg 33 2008 799 804
15. M.O. Bodendorf, V. Haas, H.G. Laberke, G. Blumenstock, P. Wex, T. Graeter Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma Lung Cancer 64 2009 71 78
16. J.M. Bréchot, S. Chevret, M.C. Charpentier Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma Correlation with TNM stage and disease free and overall survival Cancer 78 1996 2111 2118
17. F. Shoji, A. Haro, T. Yoshida Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer Ann Thorac Surg 89 2010 864 869
18. E. Ruffini, S. Asioli, P.L. Filosso Significance of the presence of microscopic vascular invasion after complete resection of stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-size categories: did the 2009 7th edition of the TNM staging system miss something? J Thorac Oncol 6 2011 319 326
19. M. Alifano, M.S. Boudaya, M. Salvi Pneumonectomy after chemotherapy: morbidity, mortality, and long-term outcome Ann Thorac Surg 85 2008 1866 1872
20. A. Stefani, M. Alifano, A. Bobbio Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients J Thorac Cardiovasc Surg 140 2010 356 363
21. A. Yoshizawa, N. Motoi, G.J. Riely Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases Mod Pathol 24 2011 653 664
22. T. Mizuno, G. Ishii, K. Nagai Identification of a low risk subgroup of stage IB lung adenocarcinoma patients Lung Cancer 62 2008 302 308
23. M. Alifano, P.E. Falcoz, V. Seegers Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancer J Thorac Cardiovasc Surg 142 2011 1161 1167